Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Long-Term Deferred Tax (2020 - 2021)

Journey Medical filings provide 2 years of Long-Term Deferred Tax readings, the most recent being $8.4 million for Q3 2021.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $8.4 million in Q3 2021 year-over-year; TTM through Sep 2021 was $8.4 million, a N/A change, with the full-year FY2020 number at $1.5 million, changed N/A from a year prior.
  • Long-Term Deferred Tax hit $8.4 million in Q3 2021 for Journey Medical, up from $1.5 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $8.4 million in Q3 2021 to a low of $1.5 million in Q4 2020.